AIM ImmunoTech is trading up 5.44% at $0.17 as of 10:44 a.m. ET on October 15, 2026, with no specific catalyst identified.
- Price context shows a modest rebound after declines in prior sessions.
- No new company-specific announcement explaining the move was identified for October 15; the latest company updates found were dated October 5 and October 7.
- Biotech-sector strength may provide a supportive backdrop, but the available evidence does not establish it as a specific catalyst.